| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12094-017-1724-0 |
| P698 | PubMed publication ID | 28766096 |
| P50 | author | Sanying Liu | Q88657342 |
| P2093 | author name string | M Lei | |
| J Zha | |||
| P2860 | cites work | Cancer statistics, 2015 | Q27860576 |
| Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance | Q28307294 | ||
| Quantitative analysis of histological staining and fluorescence using ImageJ | Q28364633 | ||
| ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions | Q29615216 | ||
| Optimization procedure for small interfering RNA transfection in a 384-well format | Q33282131 | ||
| HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells | Q33689028 | ||
| Small‐Molecule Inhibitors of the ERK Signaling Pathway: Towards Novel Anticancer Therapeutics | Q33756524 | ||
| Inhibition of ERK1/2 Restores GSK3β Activity and Protein Synthesis Levels in a Model of Tuberous Sclerosis | Q33829976 | ||
| Second-line treatment of ovarian cancer | Q33856411 | ||
| Phosphorylated Mnk1 and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma | Q35097767 | ||
| Ovarian cancer: strategies for overcoming resistance to chemotherapy | Q35166813 | ||
| Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T: A Rationale for Novel Therapeutic Approaches | Q35553279 | ||
| Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia | Q35758763 | ||
| Dissecting eIF4E action in tumorigenesis | Q36209711 | ||
| Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursors | Q36814636 | ||
| eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling | Q36920075 | ||
| Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function | Q36950337 | ||
| Inhibiting the MNK-eIF4E-β-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy | Q37709399 | ||
| Targeting the eIF4E/β-catenin axis sensitizes cervical carcinoma squamous cells to chemotherapy | Q37733009 | ||
| Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. | Q37865381 | ||
| Targeting Mnks for cancer therapy | Q37990881 | ||
| Current management of ovarian cancer | Q38434742 | ||
| Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells | Q38825129 | ||
| Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer | Q38884652 | ||
| Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy | Q39691135 | ||
| The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice | Q40388321 | ||
| Docetaxel cytotoxicity is enhanced by inhibition of the Raf/MEK/ERK signal transduction pathway | Q40605097 | ||
| Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin | Q40859019 | ||
| Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death | Q40981560 | ||
| Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery | Q43559980 | ||
| Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia | Q48057652 | ||
| Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. | Q54031538 | ||
| Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways | Q73679077 | ||
| Activation of extracellular signal-regulated kinase ERK after hypo-osmotic stress in renal epithelial A6 cells | Q80489507 | ||
| P433 | issue | 3 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 374-381 | |
| P577 | publication date | 2017-08-01 | |
| P1433 | published in | Clinical and Translational Oncology | Q15754324 |
| P1476 | title | Inhibiting ERK/Mnk/eIF4E broadly sensitizes ovarian cancer response to chemotherapy | |
| P478 | volume | 20 |
| Q65000057 | ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer. |
| Q97419627 | GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin |
| Q93183654 | Induction of MNK Kinase-dependent eIF4E Phosphorylation by Inhibitors Targeting BET Proteins Limits Efficacy of BET Inhibitors |
| Q52632734 | MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker. |
| Q64247410 | MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma |
Search more.